Stock Fundamentals

Company Information

Company Name
Indivior PLC Ordinary Shares
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: GB00BN4HT335
CIK: 0001625297
Currency: USD
Full Time Employees: 827
Phone: 804 379 1040
Fiscal Year End: December
IPO Date: Dec 29, 2014
Description:

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; and SUBOXONE Film, a buprenorphine and naloxone sublingual film. It also manufactures SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). In addition, the company is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. The company was formerly known as Indivior PLC. and changed its name to Indivior Pharmaceuticals, Inc. in January 2026. Indivior Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Address:

10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235

Directors & Officers

Name Title Year Born
Mr. Joseph J. Ciaffoni CEO & Director 1971
Mr. Ryan Preblick Chief Financial Officer 1976
Dr. Christian Heidbreder Chief Scientific Officer 1963
Mr. Jeffrey W. Burris J.D. Chief Legal Officer 1972
Mr. Patrick a. Barry Chief Commercial Officer 1968
Mr. Jason Thompson Vice President of Investor Relations NA
Mr. Kevin L. Espinoza Chief Integrity & Compliance Officer NA
Ms. Angela Colon-Mahoney M.S. Chief Human Resources Officer 1976
Ms. Vanessa Procter Executive Vice President of Corporate Affairs NA
Ms. Alice G. Givens Company Secretary 1974

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 09, 2026 Barbara Ryan N/A Purchase 31.00 $32.56 $1.01K
Mar 06, 2026 Stuart A Kingsley N/A Purchase 940.00 $31.86 $29.95K
Jan 05, 2026 Barbara Ryan N/A Purchase 775.00 $35.39 $27.43K
Jan 05, 2026 Daniel A Ninivaggi N/A Purchase 775.00 $35.39 $27.43K
Jan 05, 2026 David E Wheadon N/A Purchase 1.77K $35.39 $62.68K
Jan 05, 2026 Keith Humphreys N/A Purchase 775.00 $35.39 $27.43K
Jan 05, 2026 Mark Stejbach N/A Purchase 775.00 $35.39 $27.43K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 18.54M Mar 31, 2026 15.69% $0.01 1.71%
Vanguard Portfolio Management, LLC 7.89M Mar 31, 2026 6.68% $0.01 0.00%
Oaktree Capital Management LLC 6.98M Mar 31, 2026 5.91% $3.25 0.00%
Vanguard Capital Management, LLC 5.59M Mar 31, 2026 4.73% $0.00 0.00%
State Street Corp 4.90M Mar 31, 2026 4.15% $0.01 0.00%
Two Seas Capital LP 4.75M Mar 31, 2026 4.02% $2.02 0.00%
Millennium Management LLC 4.60M Mar 31, 2026 3.89% $0.06 0.00%
Fuller & Thaler Asset Management Inc 4.53M Mar 31, 2026 3.83% $0.46 0.00%
Madison Avenue Partners, LP 4.32M Mar 31, 2026 3.65% $5.72 -31.29%
Citadel Advisors Llc 3.57M Mar 31, 2026 3.02% $0.02 0.00%
Morgan Stanley - Brokerage Accounts 3.51M Mar 31, 2026 2.97% $0.01 0.00%
Deerfield Management Co 3.10M Mar 31, 2026 2.62% $1.11 0.00%
Geode Capital Management, LLC 2.93M Mar 31, 2026 2.48% $0.01 0.00%
Mangrove Partners 2.74M Mar 31, 2026 2.32% $6.76 0.00%
The Goldman Sachs Group Inc 2.41M Mar 31, 2026 2.04% $0.01 0.00%
Arrowstreet Capital Limited Partnership 2.32M Mar 31, 2026 1.97% $0.04 0.00%
UBS Group AG 2.19M Mar 31, 2026 1.85% $0.01 0.00%
Newtyn Management LLC 2.00M Mar 31, 2026 1.69% $6.51 -21.09%
Driehaus Capital Management LLC 1.88M Mar 31, 2026 1.59% $0.42 -6.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 1.84M Mar 31, 2026 1.55% $0.09 0.00%

Shares Statistics

Shares Outstanding: 118.20M
Shares Float: 112.94M
% Insiders: 198.00%
% Institutions: 10,889.20%
Short % Float: 10.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 7.60M 6.43% ▲ 0.04% May 29, 2026
2 Vanguard Total Stock Mkt Idx Inv 3.98M 3.37% ▲ 0.28% Apr 30, 2026
3 FullerThaler Behavioral Small-Cap Equity 3.20M 2.70% ▲ 5.85% Dec 31, 2025
4 FullerThaler Beh Small-Cap Equity SMA 3.20M 2.70% ▲ 0.00% Dec 31, 2025
5 iShares Russell 2000 ETF 2.97M 2.52% ▲ 0.93% May 29, 2026
6 Vanguard Small Cap Index 2.88M 2.44% ▼ 0.26% Apr 30, 2026
7 FullerThaler Behavioral Small-Cap Growth 2.14M 1.81% ▲ 3.67% Mar 31, 2026
8 FullerThaler Behavioral Sm-Cp Gr R6 2.08M 1.76% ▲ 9.33% Mar 31, 2026
9 Vanguard Small Cap Growth Index Inv 1.62M 1.37% ▼ 0.08% Apr 30, 2026
10 Vanguard Institutional Extnd Mkt Idx Tr 1.41M 1.19% ▲ 1.04% Apr 30, 2026

Valuation Metrics

Enterprise Value: $5.22B
Trailing P/E: 21.20
Forward P/E: 13.51

Financial Highlights

Market Cap: $4.79B
EBITDA: $475.00M
P/E Ratio: $21.20
Book Value: $-1.18
Earnings/Share: $1.91
Profit Margin: 19.53%
Operating Margin: 46.06%
ROA (TTM): 22.65%
ROE (TTM): 12.20%
Revenue (TTM): $1.29B
Revenue/Share (TTM): $10.32
Earnings Growth (YOY): 82.00%
Revenue Growth (YOY): 19.20%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 0.71x -3.36x 1.08x 5.89x 1.08x
2024-12-31 0.89x -0.99x 1.26x 0.78x 4.08x
2023-12-31 0.98x -1.30x 1.11x -4.46x -2.51x
2022-12-31 1.24x 4.84x 0.97x -2.79x -5.39x
2021-12-31 1.80x 1.23x 0.89x 8.19x 1.05x
2020-12-31 1.98x 2.95x 0.95x -6.50x -1.97x
2019-12-31 1.83x 1.16x 0.87x 8.09x 1.05x
2018-12-31 1.62x 0.06x 0.96x 10.23x 0.01x
2017-12-31 1.43x -0.02x 1.14x 8.64x 0.01x
2016-12-31 0.96x -0.34x 1.24x 6.63x 0.68x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about INDV.US!